- €4.41bn
- €10.48bn
- €11.43bn
- 49
- 79
- 54
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,807 | 8,342 | 10,294 | 11,136 | 11,434 |
Cost of Revenue | |||||
Gross Profit | 2,332 | 2,045 | 2,524 | 2,124 | 2,781 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,090 | 7,952 | 9,500 | 10,967 | 10,773 |
Operating Profit | 717 | 390 | 795 | 168 | 661 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 622 | 302 | 760 | 138 | 460 |
Provision for Income Taxes | |||||
Net Income After Taxes | 445 | 211 | 568 | 106 | 314 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 455 | 215 | 568 | 98 | 306 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 455 | 215 | 568 | 98 | 306 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.11 | 2.3 | 5.02 | 1.56 | 3.01 |
Dividends per Share |